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Diabetic Kidney Disease
Karen Ghiloni Hughes, PhD, RN, CNE, CNL
Otterbein University, Westerville, Ohio
Diabetic Kidney
Disease: Introduction
& Burden of Disease

Underlying Pathophysiology

Genetic Factors: ESRDassociated single nucleotide
polymorphism (SNP) found by
GENIE study: an intronic
SNPAF4/FMR2 family member 3;
and an intergenic SNP on
chromosome 15q26 (rs12437854)
(Reidy, et al., 2014). Sharma, et al
(2013) found that kidney tissue
from DKD patients had less
mitochondrial DNA, and lower gene
expression of PGC1-a, a regulator of
mitochondrial biogenesis. The
researchers also found 12 urine
metabolite that support suppression
of mitochondrial metabolism.

Diabetic Kidney Disease (DKD)
formerly known as diabetic
nephropathy is the most common
cause of end-stage renal disease
(ESRD) and death in patient with
diabetes (Fox, 2012; Himmelfarb, &
Tuttle, 2013).
More than 100,00 people are
diagnosed with chronic kidney disease
in the United Sates annually. More
than 20 million (or 1 in 10 Americans)
are currently living with some level of
chronic kidney disease (National
Institute of Diabetes and Digestive and
Kidney Diseases [NIDDK], 2016).
44% of newly diagnosed cases of
chronic kidney disease are caused by
diabetes (NIDDK, 2016).
DKD in the US population has risen
from 2.2% to 3.3% from1998 to 2008
(Fox, 2012), while those receiving
treatment for ESRD has increased 18
fold from 1980 to 2008 (TothManikowski, & Atta, 2015)
The annual cost of DKD in the United
states in 2009 was estimated at $18
billion (Reutens, 2013). This cost rose
to over $40 billion by 2009 (NIDDK,
2016).
At risk populations include African
Americans, American Indians, and
Hispanics/Latinos, all of whom
develop diabetes and chronic kidney
disease at higher rates than
Caucasians. As of now, the scientific
community is able to say why these
groups are more at risk. However, it is
thought to be an interplay of heredity,
diet, and comorbid conditions. High
blood pressure and hyperglycemia
increase the risk of developing DKD
(NIDDK, 2016).

Pathophysiologic Processes

Figure 1: Glomerular changes related to underlying pathophysiology. Retrieved from: http://www.kidneyinternational.org/cms/attachment/2043439544/2056050861/gr3.jpg

Various pathophysiologic pathways
lead to:
 Renal tissue mesangial cell changes
 Extracellular matrix production
 Cellular oxidative stress
 Cellular destruction
 Increase vascular permeability
 Hyperfiltration
 Albuminuria.
 All of which causes:

Glomerular
Dysfunction:
Decrease GRF

Table 1. KDOQI (2002)*clinical practice guidelines for chronic kidney
disease with clinical presentation. * no change with update in 2015;
http://www2.kidney.org/professionals/kdoqi/guidelines_ckd/p9-approach/html

Histologic Changes: At the
cellular level, expansion in the
mesangial cells form a thickened
basement membrane. In turn, there
is hyperfiltration and
glomerulosclerosis with
Kimmelsteil-Wilson nodules.
Hypertrophic changes in podocytes
allow for increased filtration of
albumin (Reidy, Kang, Hostetter, &
Susztak, 2014; Toth- Manikowski, &
Atta, 2015). These changes have
been attributed to diabetic
angiopathy, aging, atherosclerosis,
hypertension, and episodes of acute
kidney injury (Toth-Mankowski, &
Atta, 2015).
Hemodynamic Changes:
Hemodynamically, there is an
elevation of Angiotensin II and
Endothein-1 (ET-1) which results in
changes in mesangial cells and
extracellular matrix production that
increase vascular permeability and
hyperfiltration, increasing
inflammation, and hypertension
(Toth- Manikowski, & Atta, 2015).

Figure 2: Effects of Angiotensin II and Endothelin I
http://ajpregu.physiology.org/content/310/10/R877.figuresonly

Metabolic Changes: Four metabolic
pathways were noted by Toth-Mankowski
and Atta (2015) that are upregulated due
to increasing glycolysis of hyperglycemia.
These pathway (the polyol pathway, the
hexamine pathway, advances glycation end
products, and PKC pathway) result in
damage to the renal system in some
manner.
Polyol Pathway is upregulated due to
hyperglycemia. Glucose is normally
converted to sorbitol via the NADPHdependent enzyme aldose reductase, and is
then converted to fructose. When
upregulated, the polyol pathway the
reduction of glucose to sorbitol at a higher
rate results in decreased intercellular
NADPH. In turn the antioxidant glutathione
is decreased, contributing to increased
intracellular oxidative stress which may
end in cellular apoptosis.
Hexosamine pathway stems from the third
step of glycolysis that results in production
of glucosamine-6-phosphate, which is used
as a substrate to increase transcription of
inflammatory cytokines: tumor necrosis
factors-a (TNF-a) (see AGEs below) and
transforming growth factor-b1 (TGF-b1).
TGF-b1 promote renal cell hypertrophy and
increased mesangial matrix components.
Production of advanced glycation end
products (AGEs) result from irreversible
glycation of proteins that are present with
intercellular hyperglycemia. AGEs damage
cells by modifying protein function that
leads to increased permeability of
glomerular basement membrane,
expansion of the renal extracellular matrix ,
and increasing pro-inflammatory cytokines
(IL-1, IL-6, TMF-a).
Activation pf protein kinase C (PKC) stems
from the 4th step of glycolysis. PKC
increases activity of prostaglandin E2, and
NO leading to vasodilation, contributing to
glomerular hyperfiltration.

Signs and Symptoms
The diagnosis of kidney disease is
made by measuring albumin levels in
the urine (albuminuria). However, this
is detected long before the patient
shows any overt signs of kidney
disease. Albuminuria is classified by
the amount in urine in a 24 hour
period. Microalbuminuria is 30-300
mg of albumin, while
macroalbuminuria is greater than 300
mg (National Kidney Foundation,
2009).
Glomerular filtration rate (GFR) is also
calculated in order to monitor the
function of the kidney (see Table 1).
Other signs and symptoms that the
patient may notice earlier in the
disease process are weight gain and
ankle swelling. Later signs and
symptoms are described below
(National Kidney foundation, 2015).

Nursing Implications
Investigating the pathophysiology
underlying DKD has allowed advanced
nurse practitioners to adequately screen
patient with diabetes for albuminuria
prior to overt clinical symptomology.
Glycemic control is paramount to the
treatment of the diabetic patient in order
to stall the progression of kidney disease.
The National Kidney Foundation
(2015) recommends annual screening
for patients with diabetes to include Hgb
A1C, blood pressure, BUN, creatinine,
and urine albumin levels. Treatment for
high blood pressure with ACE inhibitors
or ARBs to interrupt the reninangiotensin-aldosterone system (RAAS)
is also recommended.
Pt education regarding the need for
glycemic and blood pressure control is
also needed. Advanced practitioners
must address diet as a means of not only
glycemic control, but also as a major
influence on blood pressure levels, and
obesity.

Conclusion
http://image.slidesharecdn.com/ckd-151109200735-lva1-app6892/95/chronic-renal-disease-ckd-4-638.jpg?cb=1447099731

Significance of
Pathophysiology
Understanding the complex
interconnection of the pathophysiology
of DKD will allow the advance nurse
practitioner to appropriately treat the
patient at risk for DKD.
The pathophysiology includes
cellular changes brought on by genetic
factors, dysfunction in the glycolysis
pathways, renal mesangial changes,
extracellular matric production,
oxidative stress and destruction,
increased vascular permeability and
hyperfiltration. These mechanisms
generate the resulting albuminuria and
decreasing GFR that are hallmark for
DKD..

It is well documented that DKD not
only creates a large financial burden on
the United States, but greatly adds to the
morbidity and mortality of the patient
with diabetes. DKD is a complex interplay
of various pathophysiologic mechanisms.
The advanced nurse practitioner must
fully understand the mechanism at play
in DKD and the resulting insult to the
renal tissue. This understanding allows
the advanced nurse practitioner to
properly educate and treat patients at
risk for DKD.
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